Trellus Health PLC
LSE:TRLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Trellus Health PLC
Net Change in Cash
Trellus Health PLC
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Net Change in Cash
-$7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Net Change in Cash
-£261k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Genincode PLC
LSE:GENI
|
Net Change in Cash
-£1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PHSC PLC
LSE:PHSC
|
Net Change in Cash
-£270.6k
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Iconic Labs PLC
LSE:ICON
|
Net Change in Cash
-£93.6k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Trellus Health PLC
Glance View
Trellus Health Plc engages in the provision of digital chronic condition management solutions for employers and health plans. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2021-05-28. The firm is commercializing digital chronic condition management solutions for employers and health plans that utilize the scientifically validated Gaining Resilience Through Transitions (GRITT) resilience-based methodology and a proprietary HIPAA compliant technology platform called TrellusElevate, to coordinate and deliver personalized care remotely through telemedicine. The firm is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
See Also
What is Trellus Health PLC's Net Change in Cash?
Net Change in Cash
-7.8m
USD
Based on the financial report for Dec 31, 2024, Trellus Health PLC's Net Change in Cash amounts to -7.8m USD.
What is Trellus Health PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
-13%
Over the last year, the Net Change in Cash growth was -13%.
